Theratechnologies Inc. (TH) - Cash Flow Conversion Efficiency

Latest as of May 2025: -0.095x

Based on the latest financial reports, Theratechnologies Inc. (TH) has a cash flow conversion efficiency ratio of -0.095x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$2.66 Million ≈ $1.92 Million USD) by net assets (CA$-27.92 Million ≈ $-20.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TH equity to assets ratio to measure how much of total assets are equity-financed.

Theratechnologies Inc. - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how Theratechnologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Theratechnologies Inc. to evaluate the quality of earnings relative to operating cash generation.

Theratechnologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theratechnologies Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Southern Silver Exploration Corp.
V:SSV
-0.024x
Inission AB (publ)
ST:INISS-B
0.058x
Ekovest Bhd
KLSE:8877
0.159x
Bonterra Energy Corp
TO:BNE
0.022x
Casa de Bolsa Finamex S.A.B. de C.V
MX:FINAMEXO
0.039x
GOLFZON Co. Ltd
KQ:215000
0.052x
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS
0.041x
Fong Chien Construction Co Ltd
TWO:5523
-0.115x

Annual Cash Flow Conversion Efficiency for Theratechnologies Inc. (1996–2024)

The table below shows the annual cash flow conversion efficiency of Theratechnologies Inc. from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see Theratechnologies Inc. (TH) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-11-30 CA$-25.27 Million
≈ $-18.28 Million
CA$2.38 Million
≈ $1.72 Million
-0.094x -134.60%
2023-11-30 CA$-20.87 Million
≈ $-15.10 Million
CA$-5.68 Million
≈ $-4.11 Million
0.272x -58.20%
2022-11-30 CA$-22.57 Million
≈ $-16.33 Million
CA$-14.69 Million
≈ $-10.63 Million
0.651x +179.85%
2021-11-30 CA$17.76 Million
≈ $12.85 Million
CA$-14.48 Million
≈ $-10.47 Million
-0.815x +80.61%
2020-11-30 CA$3.22 Million
≈ $2.33 Million
CA$-13.55 Million
≈ $-9.80 Million
-4.204x -2978.87%
2019-11-30 CA$24.83 Million
≈ $17.96 Million
CA$-3.39 Million
≈ $-2.45 Million
-0.137x -1331.40%
2018-11-30 CA$35.05 Million
≈ $25.36 Million
CA$-334.40K
≈ $-241.90K
-0.010x -116.76%
2017-11-30 CA$33.51 Million
≈ $24.24 Million
CA$1.91 Million
≈ $1.38 Million
0.057x -43.11%
2016-11-30 CA$20.02 Million
≈ $14.48 Million
CA$2.00 Million
≈ $1.45 Million
0.100x -71.72%
2015-11-30 CA$14.98 Million
≈ $10.83 Million
CA$5.30 Million
≈ $3.83 Million
0.354x +134.63%
2014-11-30 CA$6.87 Million
≈ $4.97 Million
CA$-7.02 Million
≈ $-5.08 Million
-1.022x -144.46%
2013-11-30 CA$17.45 Million
≈ $12.62 Million
CA$-7.29 Million
≈ $-5.28 Million
-0.418x +39.39%
2012-11-30 CA$22.82 Million
≈ $16.51 Million
CA$-15.74 Million
≈ $-11.39 Million
-0.690x +7.92%
2011-11-30 CA$35.20 Million
≈ $25.46 Million
CA$-26.36 Million
≈ $-19.07 Million
-0.749x -1459.83%
2010-11-30 CA$51.65 Million
≈ $37.36 Million
CA$2.84 Million
≈ $2.06 Million
0.055x -58.09%
2009-11-30 CA$40.70 Million
≈ $29.44 Million
CA$5.35 Million
≈ $3.87 Million
0.131x +114.60%
2008-11-30 CA$37.80 Million
≈ $27.35 Million
CA$-34.03 Million
≈ $-24.62 Million
-0.900x -83.28%
2007-11-30 CA$65.94 Million
≈ $47.70 Million
CA$-32.39 Million
≈ $-23.43 Million
-0.491x +5.50%
2006-11-30 CA$38.96 Million
≈ $28.18 Million
CA$-20.25 Million
≈ $-14.65 Million
-0.520x -487.37%
2005-11-30 CA$41.96 Million
≈ $30.35 Million
CA$-3.71 Million
≈ $-2.69 Million
-0.088x +74.68%
2004-11-30 CA$53.02 Million
≈ $38.35 Million
CA$-18.53 Million
≈ $-13.40 Million
-0.349x -6.85%
2003-11-30 CA$64.48 Million
≈ $46.65 Million
CA$-21.09 Million
≈ $-15.26 Million
-0.327x -72.10%
2002-11-30 CA$79.51 Million
≈ $57.52 Million
CA$-15.11 Million
≈ $-10.93 Million
-0.190x -58.13%
2001-11-30 CA$70.95 Million
≈ $51.32 Million
CA$-8.53 Million
≈ $-6.17 Million
-0.120x -1.33%
2000-11-30 CA$38.53 Million
≈ $27.87 Million
CA$-4.57 Million
≈ $-3.31 Million
-0.119x +40.93%
1999-11-30 CA$16.91 Million
≈ $12.23 Million
CA$-3.40 Million
≈ $-2.46 Million
-0.201x +38.66%
1998-11-30 CA$10.94 Million
≈ $7.91 Million
CA$-3.58 Million
≈ $-2.59 Million
-0.327x +35.81%
1997-11-30 CA$7.03 Million
≈ $5.08 Million
CA$-3.58 Million
≈ $-2.59 Million
-0.510x -102.72%
1996-11-30 CA$11.80 Million
≈ $8.54 Million
CA$-2.97 Million
≈ $-2.15 Million
-0.252x --

About Theratechnologies Inc.

TO:TH Canada Biotechnology
Market Cap
$148.68 Million
CA$205.53 Million CAD
Market Cap Rank
#17637 Global
#563 in Canada
Share Price
CA$4.47
Change (1 day)
-4.89%
52-Week Range
CA$4.37 - CA$4.70
All Time High
CA$58.28
About

Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatm… Read more